Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-10 10:10 am Sale |
2024-07-09 | 13G | ShockWave Medical, Inc. SWAV |
FMR LLC | 0 0.000% |
-2,039,230 (Position Closed) |
Filing History |
| 2024-07-10 10:10 am Purchase |
2024-07-09 | 13G | Lamb Weston Holdings, Inc. LW |
FMR LLC | 15,923,246 11.027% |
14,264,837 (+860.15%) |
Filing History |
| 2024-07-10 10:10 am Purchase |
2024-07-09 | 13G | Diodes Incorporated DIOD |
FMR LLC | 4,838,016 10.489% |
2,617,816 (+117.91%) |
Filing History |
| 2024-07-10 10:10 am Sale |
2024-07-09 | 13G | Evolent Health, Inc. EVH |
FMR LLC | 6,320,807 5.429% |
-6,569,922 (-50.97%) |
Filing History |
| 2024-07-08 4:15 pm Unchanged |
2024-06-28 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA |
FMR LLC | 8,622,468 5.400% |
0 (Unchanged) |
Filing History |
| 2024-07-08 1:07 pm Purchase |
2024-06-28 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA |
FMR LLC | 8,622,468 5.400% |
8,622,468 (New Position) |
Filing History |
| 2024-06-24 12:59 pm Purchase |
2024-06-20 | 13D | Fidelity Multi-Strategy Credit Fund | FMR LLC | 995 72.995% |
266 (+36.49%) |
Filing |
| 2024-06-10 09:48 am Purchase |
2024-06-07 | 13G | Nova Ltd. NVMI |
FMR LLC | 2,904,462 10.000% |
487,658 (+20.18%) |
Filing History |
| 2024-06-10 09:48 am Purchase |
2024-06-07 | 13G | FIDELITY GREENWOOD STR TR HEDG FHEQ |
FMR LLC | 17,535,891 98.654% |
17,535,891 (New Position) |
Filing History |
| 2024-06-10 09:48 am Sale |
2024-06-07 | 13G | Spyre Therapeutics, Inc. SYRE |
FMR LLC | 6,583,155 12.963% |
-1,020 (-0.02%) |
Filing History |
| 2024-06-10 09:48 am Purchase |
2024-06-07 | 13G | Sage Therapeutics, Inc. SAGE |
FMR LLC | 6,302,474 10.472% |
819,997 (+14.96%) |
Filing History |
| 2024-06-10 09:48 am Purchase |
2024-06-07 | 13G | Foghorn Therapeutics Inc. FHTX |
FMR LLC | 6,303,217 11.392% |
3,493,208 (+124.31%) |
Filing History |
| 2024-06-10 09:48 am Purchase |
2024-06-07 | 13G | Okta, Inc. OKTA |
FMR LLC | 16,950,896 10.526% |
1,435,543 (+9.25%) |
Filing History |
| 2024-06-10 09:48 am Purchase |
2024-06-07 | 13G | Fidelity Quality Factor ETF FQAL |
FMR LLC | 8,228,260 48.259% |
2,695,136 (+48.71%) |
Filing History |
| 2024-06-10 09:48 am Purchase |
2024-06-07 | 13G | Proficient Auto Logistics, Inc. Common Stock PAL |
FMR LLC | 3,458,204 14.341% |
3,458,204 (New Position) |
Filing History |
| 2024-06-10 09:48 am Purchase |
2024-06-07 | 13G | Fidelity International Value Factor ETF FIVA |
FMR LLC | 1,647,891 29.961% |
40,501 (+2.52%) |
Filing History |
| 2024-05-30 10:45 am Purchase |
2024-05-29 | 13D | Fidelity Private Credit Fund | FMR LLC | 946 7.946% |
946 (New Position) |
Filing |
| 2024-05-10 10:10 am Sale |
2024-05-09 | 13G | Fidelity Covington Trust - Enhanced Large Cap Value ETF FELV |
FMR LLC | 4,320,526 6.774% |
-4,608,227 (-51.61%) |
Filing History |
| 2024-05-10 10:03 am Unchanged |
2024-05-09 | 13G | Vasta Platform Limited VSTA |
FMR LLC | 1,725,714 10.417% |
0 (Unchanged) |
Filing History |
| 2024-05-10 10:03 am Purchase |
2024-05-09 | 13G | iShares MSCI Emerging Markets Multifactor ETF EMGF |
FMR LLC | 1,913,058 14.066% |
1,913,058 (New Position) |
Filing History |